Osterweis Capital Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$16.9M Sell
88,075
-22,920
-21% -$3.73M 0.84% 39
2026
Q2
$15.1M Buy
110,995
+18,775
+20% +$2.31M 0.71% 46
2026
Q1
$10.9M Buy
92,220
+37,585
+69% +$5.25M 0.56% 56
2025
Q4
$8.95M Sell
54,635
-18,295
-25% -$2.87M 0.38% 68
2025
Q3
$9.7M Buy
+72,930
New +$8.86M 0.44% 64
2025
Q2
– Sell
-72,765
Closed -$9.26M – 399
2025
Q1
$9.26M Buy
72,765
+11,080
+18% +$1.71M 0.46% 67
2024
Q4
$8.88M Buy
61,685
+8,240
+15% +$1.18M 0.41% 73
2024
Q3
$7.95M Buy
53,445
+17,410
+48% +$2.5M 0.4% 76
2024
Q2
$4.54M Buy
+36,035
New +$5.65M 0.23% 84

Other funds holding RGEN

Osterweis Capital Management's RGEN Position: Q3 2026 in Review

Osterweis Capital Management reduced its Repligen (RGEN) stake by 21% in Q3 2026, selling an estimated $3.73M and leaving 88,075 shares worth $16.9M. The position accounts for 0.84% of the portfolio, ranked #39.

Osterweis Capital Management first reported a position in RGEN in Q2 2024 and has held it in 9 quarters since. 524 funds tracked by Wall St. Rank hold RGEN as of Q3 2026.

  • Osterweis Capital Management held 88,075 shares of Repligen worth $16.9M as of Q3 2026.
  • Osterweis Capital Management sold 22,920 Repligen shares in Q3 2026, an estimated $3.73M.
  • Repligen made up 0.84% of Osterweis Capital Management's portfolio in Q3 2026, its #39 holding.
  • Osterweis Capital Management first reported a position in Repligen in Q2 2024 and has held it in 9 quarters since.
  • 524 funds tracked by Wall St. Rank held Repligen as of Q3 2026.

Based on Osterweis Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.